Manifold pricing gives 77.34% probability that Apple releases a dedicated AI chip for iPhones in 2026, signaling...
Manifold pricing gives 77.34% probability that Apple releases a dedicated AI chip for iPhones in 2026, signaling accelerated in-house AI silicon.
confidence score
Strong evidence: 2 independent source classes support this read.
AAPL has not made a large direction-matching 30-90 day move yet.
signal brief
Manifold pricing gives 77.34% probability that Apple releases a dedicated AI chip for iPhones in 2026, signaling accelerated in-house AI silicon. The same platform shows only 27.63% likelihood Apple remains partnered with OpenAI in 2028, consistent with an in-house AI model and chip strategy. A dedicated iPhone AI chip would deepen Apple's custom silicon moat, add advanced-node demand to TSMC's N3/N2 pipeline, and pressure smartphone rivals' AI hardware roadmaps. It would also reduce dependency on external AI accelerators and potentially on LLM partners over time. Direction is up for AAPL's edge-AI competitiveness and for TSMC as the leading-edge foundry partner; confidence is low because the source is prediction-market consensus rather than official product news.
What the sources said:
- "Manifold consensus on 'Will Apple release an AI chip for iPhones in 2026?': YES=77.34%" (https://manifold.markets/irilonto/will-apple-release-an-ai-chip-for-i)
- "Manifold consensus on 'Will Apple still be partnered with OpenAI in 2028?': YES=27.63%" (https://manifold.markets/CampbellHutcheson/will-apple-still-be-partnered-with)
source data used
“Polymarket top market 'Will Apple be the largest company in the world by market cap on December 31?': YES=19.80%”
“Manifold consensus on 'Will Apple release an AI chip for iPhones in 2026?': YES=77.34%”
“Manifold consensus on 'Will Apple still be partnered with OpenAI in 2028?': YES=27.63%”
“Manifold consensus on 'Will any 4 of AAPL, AMZN, ASML, GOOG, META, MSFT, NVDA, and TSM lose 60% of their peak value before 2028?': YES=24.53%”
spillover entities
Decision support, not stock advice. This signal is research with cited evidence — not a recommendation to buy, sell, or hold any security.